Rockefeller Capital Management’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-14,702
| Closed | -$72K | – | 1814 |
|
|
2023
Q1 | $72K | Buy |
14,702
+77
| +0.5% | +$377 | ﹤0.01% | 1909 |
|
|
2022
Q4 | $91K | Buy |
14,625
+542
| +4% | +$3.37K | ﹤0.01% | 2077 |
|
|
2022
Q3 | $151K | Buy |
14,083
+1,248
| +10% | +$13.4K | ﹤0.01% | 1779 |
|
|
2022
Q2 | $146K | Sell |
12,835
-27,754
| -68% | -$316K | ﹤0.01% | 1752 |
|
|
2022
Q1 | $369K | Buy |
40,589
+7,943
| +24% | +$72.2K | ﹤0.01% | 1440 |
|
|
2021
Q4 | $486K | Buy |
32,646
+22,646
| +226% | +$337K | ﹤0.01% | 1331 |
|
|
2021
Q3 | $257K | Buy |
+10,000
| New | +$257K | ﹤0.01% | 1502 |
|
|
2021
Q1 | – | Sell |
-3,054
| Closed | -$77K | – | 3236 |
|
|
2020
Q4 | $77K | Buy |
+3,054
| New | +$77K | ﹤0.01% | 1541 |
|